Real-Time, Noninvasive Diagnosis of Bullous Pemphigoid: Diagnostic Performance of Line-Field Confocal Optical Coherence Tomography

实时、无创诊断大疱性类天疱疮:线场共聚焦光学相干断层扫描的诊断性能

阅读:1

Abstract

BACKGROUND: Bullous pemphigoid (BP) is a common autoimmune blistering dermatosis often difficult to distinguish from other inflammatory conditions. Timely diagnosis is crucial for appropriate management. Line-field confocal optical coherence tomography (LC-OCT), a noninvasive imaging technique that uses an 800nm laser to generate high-resolution vertical and horizontal cross-sectional images of the skin, is evaluated as a diagnostic tool for BP. MATERIALS AND METHODS: A prospective, single-center study was conducted on 26 patients with suspected BP. LC-OCT imaging, histopathology, and direct immunofluorescence (DIF) were performed. LC-OCT images were assessed for the presence of key diagnostic features, including subepidermal cleavage and eczema criteria. RESULTS: Based on histopathology, DIF, indirect immunofluorescence (IIF), and ELISA, the final diagnoses were 15 BP cases and 11 non-BP cases. LC-OCT correctly identified 12 of 15 BP cases and all 11 non-BP cases, demonstrating a sensitivity of 0.8 and a specificity of 1.0. The presence of subepidermal cleavage was a key diagnostic criterion for BP (p = 0.000). The absence of alternating hypo- and hyper-reflective layers (p = 0.000), thickened and disrupted stratum corneum (p = 0.014), spongiosis (p = 0.036), and thickened epidermis (p = 0.043), which occurred significantly less frequently in BP cases, further supported the diagnosis. CONCLUSION: LC-OCT demonstrates high sensitivity and specificity in diagnosing BP, offering a rapid, point-of-care diagnostic approach. LC-OCT can be used to evaluate unclear inflammatory skin conditions and guide further investigations. However, LC-OCT has limitations in diagnosing non-bullous stages of BP; thus, histology and DIF remain the gold standard for definitive diagnosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。